Transcranial photobiomodulation influences BOLD responses during finger sequence execution: An fMRI Study in young and older adults.
Published November 11, 2026. In 56 healthy adults, one 24-minute transcranial photobiomodulation session was followed by local changes in task-related fMRI BOLD responses in several motor and premotor regions among older participants. The stimulation did not improve finger-sequence performance compared with sham in either age group. BOLD is an indirect blood-oxygen signal, so the study does not show better movement, cognition, daily functioning or treatment of an age-related condition.
Dole M, Auboiroux V, Anglade D, Cousin E, Baciu M, Sandre-Ballester C, Rebecchi S, Cantat-Moltrecht T, Mitrofanis J.
NeuroImage · Publication date: 2026-11-11
Added to site: 2026-11-17
DOI: 10.1016/j.neuroimage.2026.122351
Published online November 11, 2026. Added to Neurofeedback.com November 17, 2026 after comparison with fresh and retained candidates. The source publication date is separate from the site addition date.
- Modalities
- Transcranial photobiomodulation, Functional MRI, Red and near-infrared light
- Clinical focus
- Healthy aging, Motor-sequence execution, BOLD response and behavior
- Population
- Right-handed cognitively healthy adults, 29 younger adults ages 18 to 40 and 27 older adults ages 60 to 85 in the analyzed sample
- Sample
- 60 enrolled, 56 analyzed after one experimental-error exclusion, two incidental MRI findings and one prespecified-style behavioral-outlier exclusion
- Intervention / method
- Participants completed separate active and sham visits in balanced randomized order. Each visit included finger-sequence fMRI before and after a 24-minute session. Active stimulation used a commercially available whole-head helmet with 40 red 670-nm LEDs and 40 near-infrared 810-nm LEDs; participants wore an eye mask during active and sham sessions. The registered study was NCT05845216.
- Comparator
- Within-participant sham stimulation with balanced active-first and sham-first order
Clinician summary
The analyzed crossover sample included 29 younger and 27 older adults. In older participants, PBM-versus-sham pre-to-post BOLD differences survived FDR correction in the left primary motor cortex, right dorsal and ventral premotor cortices, right putamen and supplementary motor area; the age-by-timing-by-treatment interaction was significant only in the right dorsal premotor cortex and supplementary motor area. Behavioral change was null in older adults, p=0.296, and did not reach significance in younger adults, p=0.092. The source emphasizes that neural and vascular contributions to the BOLD signal cannot be separated here.
How to interpret the findings
This was a single-session healthy-volunteer experiment with no patient population, symptom outcome, daily-function measure or follow-up. Participants but not investigators were blinded. Four enrolled participants were excluded, including one older behavioral outlier. The study tested many regions and reports both corrected and exploratory uncorrected imaging results. Increased BOLD signal is not necessarily beneficial and did not translate into faster finger-sequence performance. The study cannot determine how much of the signal was neural versus vascular, whether light reached each cortical target uniformly, whether effects persist or whether repeated sessions are safe or useful. The checked full text did not identify an adverse-event result.
Equipment and disclosures
The study used the source-named WellRed Coronet Duo whole-head photobiomodulation helmet. Reporting the device and wavelengths documents the protocol and does not establish device superiority, clinical effectiveness or an association with BrainMaster or another site sponsor.
The authors declared no known competing financial interests or personal relationships. The project was privately funded by the COVEA Foundation through Fonds Clinatec. The acknowledgments thank two representatives of WellRed, maker of the commercially available helmet used in the study, for help with the ethics submission. No correction, retraction or expression-of-concern notice tied to the DOI appeared in the checked PubMed, publisher or bounded DOI searches on November 17, 2026; this is not assurance of absence. The publisher labels the article open access. AI-assisted source review for Neurofeedback.com, not independent human clinical review.
Related evidence
Compare findings from the same clinical area, including mixed results.
Summary prepared with AI assistance. Source verification does not imply an independent replication or a clinician's endorsement. Read our review method.